Shao J - Search Results

1

A dityrosyl-diiron radical cofactor center is essential for human ribonucleotide reductases.

Zhou B, Shao J, Su L, Yuan YC, Qi C, Shih J, Xi B, Chu B, Yen Y. Zhou B, et al. Among authors: shao j. Mol Cancer Ther. 2005 Dec;4(12):1830-6. doi: 10.1158/1535-7163.MCT-05-0273. Mol Cancer Ther. 2005. PMID: 16373698

2

Ribonucleotide reductase inhibitors and future drug design.

Shao J, Zhou B, Chu B, Yen Y. Shao J, et al. Curr Cancer Drug Targets. 2006 Aug;6(5):409-31. doi: 10.2174/156800906777723949. Curr Cancer Drug Targets. 2006. PMID: 16918309 Review.

3

In vitro characterization of enzymatic properties and inhibition of the p53R2 subunit of human ribonucleotide reductase.

Shao J, Zhou B, Zhu L, Qiu W, Yuan YC, Xi B, Yen Y. Shao J, et al. Cancer Res. 2004 Jan 1;64(1):1-6. doi: 10.1158/0008-5472.can-03-3048. Cancer Res. 2004. PMID: 14729598

4

Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assay.

Shao J, Zhou B, Zhu L, Bilio AJ, Su L, Yuan YC, Ren S, Lien EJ, Shih J, Yen Y. Shao J, et al. Biochem Pharmacol. 2005 Feb 15;69(4):627-34. doi: 10.1016/j.bcp.2004.11.016. Epub 2005 Jan 8. Biochem Pharmacol. 2005. PMID: 15670581

5

Characterization of enzymatic properties of human ribonucleotide reductase holoenzyme reconstituted in vitro from hRRM1, hRRM2, and p53R2 subunits.

Qiu W, Zhou B, Darwish D, Shao J, Yen Y. Qiu W, et al. Among authors: shao j. Biochem Biophys Res Commun. 2006 Feb 10;340(2):428-34. doi: 10.1016/j.bbrc.2005.12.019. Epub 2005 Dec 15. Biochem Biophys Res Commun. 2006. PMID: 16376858

6

A Ferrous-Triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase.

Shao J, Zhou B, Di Bilio AJ, Zhu L, Wang T, Qi C, Shih J, Yen Y. Shao J, et al. Mol Cancer Ther. 2006 Mar;5(3):586-92. doi: 10.1158/1535-7163.MCT-05-0384. Mol Cancer Ther. 2006. PMID: 16546972

7

Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma.

Zhu L, Somlo G, Zhou B, Shao J, Bedell V, Slovak ML, Liu X, Luo J, Yen Y. Zhu L, et al. Among authors: shao j. Mol Cancer Ther. 2005 May;4(5):787-98. doi: 10.1158/1535-7163.MCT-04-0330. Mol Cancer Ther. 2005. PMID: 15897243

8

Inhibitory mechanisms of heterocyclic carboxaldehyde thiosemicabazones for two forms of human ribonucleotide reductase.

Zhu L, Zhou B, Chen X, Jiang H, Shao J, Yen Y. Zhu L, et al. Among authors: shao j. Biochem Pharmacol. 2009 Nov 1;78(9):1178-85. doi: 10.1016/j.bcp.2009.06.103. Epub 2009 Jul 2. Biochem Pharmacol. 2009. PMID: 19576866

9

Targeting ribonucleotide reductase for cancer therapy.

Shao J, Liu X, Zhu L, Yen Y. Shao J, et al. Expert Opin Ther Targets. 2013 Dec;17(12):1423-37. doi: 10.1517/14728222.2013.840293. Epub 2013 Oct 1. Expert Opin Ther Targets. 2013. PMID: 24083455 Review.

10

Non-enzymatic action of RRM1 protein upregulates PTEN leading to inhibition of colorectal cancer metastasis.

Qi H, Lou M, Chen Y, Liu X, Chen N, Shan J, Ling Z, Shen J, Zhu L, Yen Y, Zheng S, Shao J. Qi H, et al. Among authors: shao j. Tumour Biol. 2015 Jun;36(6):4833-42. doi: 10.1007/s13277-015-3137-4. Epub 2015 Feb 1. Tumour Biol. 2015. PMID: 25638032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,689 results

Search Page

Filters